Vertex’s latest FDA nod could boost sales by $150M: analyst
August 02, 2017 at 11:58 AM EDT
The Boston-based company said Tuesday that the FDA had approved its cystic fibrosis drug Kalydeco for use in more than 600 additional patients with the lung disease.
